» Articles » PMID: 10439796

Efficiency of Ber-EP4 Antibody for Isolating Circulating Epithelial Tumor Cells Before RT-PCR Detection

Overview
Specialty Pathology
Date 1999 Aug 10
PMID 10439796
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

We compared the efficacy of 4 methods for isolating circulating tumor cells: immunocapture with Ber-EP4-coated magnetic beads, density gradient separation, ammonium chloride, and distilled water-mediated erythrocyte lysis. Human blood from healthy volunteers was mixed with serial dilutions of prostate (LNCaP) and liver (HepG2) derived tumor cells. Isolation of circulating tumor cells was followed by reverse transcriptase-polymerase chain reaction with primers specific for prostate-specific antigen and alpha-fetoprotein. Ber-EP4 antigen expression was evaluated by immunohistochemistry in 27 hepatocellular carcinomas and 34 prostate adenocarcinomas. Peripheral blood samples from 12 patients with hepatocellular carcinoma and 10 with prostate adenocarcinoma also were tested. Density gradient separation and Ber-EP4 immunocapture were the most sensitive techniques for isolating circulating tumor cells in in vitro tests. Isolation by density gradient separation was significantly more sensitive than Ber-EP4 immunocapture when applied to peripheral blood samples of patients with cancer, a result consistent with the variable expression of Ber-EP4 antigen that we found by immunohistochemistry in prostate adenocarcinomas and hepatocellular carcinomas.

Citing Articles

Comparison of sample preparation methods for rare cell isolation in microfluidic devices.

Varillas J, Chen K, Dopico P, Zhang J, George T, Fan Z Can J Chem. 2022; 100(7):512-519.

PMID: 36338875 PMC: 9635407. DOI: 10.1139/cjc-2021-0229.


Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.

Cui K, Ou Y, Shen Y, Li S, Sun Z Medicine (Baltimore). 2020; 99(40):e22242.

PMID: 33019399 PMC: 7535562. DOI: 10.1097/MD.0000000000022242.


Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer.

Broncy L, Paterlini-Brechot P Cells. 2019; 8(7).

PMID: 31277346 PMC: 6678597. DOI: 10.3390/cells8070676.


Isolation of circulating tumor cells in patients undergoing surgery for esophageal cancer and a specific confirmation method.

Zhao Y, Zhao S, Chen Y, Dong X, Peng C, Sun Q Oncol Lett. 2019; 17(4):3817-3825.

PMID: 30881502 PMC: 6403499. DOI: 10.3892/ol.2019.10017.


Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule.

Witek M, Aufforth R, Wang H, Kamande J, M Jackson J, Pullagurla S NPJ Precis Oncol. 2018; 1.

PMID: 29657983 PMC: 5871807. DOI: 10.1038/s41698-017-0028-8.